Prospective In Vitro Models of Channelopathies and Cardiomyopathies
An in vitro heart disease model is a promising model used for identifying the genes responsible for the disease, evaluating the effects of drugs, and regenerative medicine. We were interested in disease models using a patient-induced pluripotent stem (iPS) cell-derived cardiomyocytes because of thei...
Main Authors: | Nanako Kawaguchi, Emiko Hayama, Yoshiyuki Furutani, Toshio Nakanishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2012/439219 |
Similar Items
-
Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
by: Beidi Lan, et al.
Published: (2015-01-01) -
Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model
by: Tingting Zhang, et al.
Published: (2020-05-01) -
Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia
by: Tingting Zhang, et al.
Published: (2019-04-01) -
The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies
by: Nicoleta-Monica Popa-Fotea, et al.
Published: (2020-07-01) -
Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies
by: Simona Magi, et al.
Published: (2017-08-01)